Product Overview
Elravie Premier is a Korean hyaluronic acid (HA) dermal filler collection developed and manufactured by Humedix Co., Ltd. The range includes Soft, Light, Deep Line and Ultra Volume formulations, each designed with different gel characteristics for professional facial aesthetic applications. These injectable medical devices use cross-linked hyaluronic acid to provide temporary soft-tissue correction. The documented lidocaine formulations contain 0.3% lidocaine, while HA concentration varies by product and market-specific presentation. Elravie Premier is available in prefilled syringes, including 1 mL formulations and a documented 2 mL Ultra Volume presentation.
Key Features
- Four Distinct HA Filler Formulations: Elravie Premier Soft, Light, Deep Line and Ultra Volume offer different gel characteristics and correction profiles. Product selection should reflect the approved intended use and specifications of each formulation.
- Cross-Linked Hyaluronic Acid: The collection uses cross-linked HA to provide temporary soft-tissue filling and mechanical support. Published HA concentrations differ across formulations and certain regional versions.
- 0.3% Lidocaine Formulations: Manufacturer-documented lidocaine versions contain 0.3% (3 mg/mL) lidocaine, a local anesthetic included to help reduce injection-related discomfort.
- Humedix HA Manufacturing Technology: Humedix describes a high-purity HA production process incorporating tangential-flow filtration and proprietary HA cross-linking technology to achieve the intended characteristics of its filler formulations.
- Multiple Syringe Presentations: The documented Premier range includes 1 mL prefilled syringes, while Ultra Volume is also available in a 2 mL presentation in certain markets. Accessories and packaging differ by SKU.
Composition & Specifications
| Specification | Details |
|---|---|
| Product Family | Elravie Premier |
| Manufacturer | Humedix Co., Ltd. |
| Country of Origin | Republic of Korea |
| Product Category | Injectable hyaluronic acid dermal filler / tissue-augmentation medical device |
| Primary Material | Cross-linked hyaluronic acid (sodium hyaluronate) |
| Available Formulations | Soft, Light, Deep Line and Ultra Volume |
| Hyaluronic Acid Concentration | Formulation-dependent. Soft: 15 mg/mL; Light: 20 mg/mL in the manufacturer's portfolio brochure, while a separately listed Light-LC export presentation specifies 23 mg/mL; Deep Line and Ultra Volume: 23 mg/mL. |
| Lidocaine Content | 0.3% (3 mg/mL) in documented lidocaine-containing formulations |
| HA Production Technology | Humedix high-purity HA manufacturing process, including tangential-flow filtration (TFF); proprietary HA cross-linking technology |
| Dosage Form | Sterile, prefilled HA gel syringe |
| Documented Syringe Volumes | 1 mL; 2 mL also documented for Ultra Volume |
| Packaging | Generally 1 prefilled syringe per box for the documented Premier presentations. Included needles and cannulas vary by product and market. |
| Storage | 1–30°C; protect from light and do not freeze, according to Humedix product information |
| Intended Users | Appropriately qualified healthcare professionals |
Elravie Premier specifications can differ by formulation, market and labeling version. In particular, published Light-L and Light-LC HA concentrations are not consistent across Humedix materials. Confirm the exact product name, HA concentration, lidocaine status, syringe volume and accessories against the original carton and current market-specific Instructions for Use.
How Elravie Premier Works
Hyaluronic acid is a naturally occurring glycosaminoglycan found in the extracellular matrix. Its ability to bind water contributes to tissue hydration and structure. In an injectable dermal filler, cross-linking creates a more stable HA gel that can provide temporary soft-tissue filling and support.
Elravie Premier uses Humedix's HA manufacturing expertise, including a purification process based on tangential-flow filtration. The manufacturer describes its high-purity HA processing and cross-linking technology as important elements of the product's formulation characteristics.
The different Elravie Premier formulations are distinguished by their intended correction profiles and material properties. HA concentration is one consideration, but gel elasticity, cohesivity and other rheological characteristics also influence filler behavior. A higher HA concentration does not necessarily indicate a better product or a longer clinical duration.
Lidocaine-containing presentations additionally provide a local anesthetic component. Lidocaine temporarily blocks nerve signal conduction and is included to help manage injection-related discomfort. Product-specific labeling and contraindications must be reviewed before professional use.
Available Variants
The Elravie Premier range includes four principal formulations. Soft, Light, Deep Line and Ultra Volume are differentiated by their material characteristics and labeled indications. The following comparison summarizes manufacturer-documented presentations rather than assuming every formulation is available in every destination market.
| Product | HA Concentration | Product Characteristics | Documented Volume |
|---|---|---|---|
| Elravie Premier Soft | 15 mg/mL | Soft formulation within the Premier range. Humedix's Korean product information describes temporary correction of nasolabial folds in adults. | 1 mL |
| Elravie Premier Light-L / Light-LC | 20 mg/mL in the Premier portfolio brochure; 23 mg/mL in the Light-LC export listing | Light formulation for the correction profile specified in its approved labeling. Concentration must be confirmed by SKU. | 1 mL |
| Elravie Premier Deep Line-L / Deep Line-LC | 23 mg/mL | Formulation positioned for temporary facial wrinkle correction, including deeper fold correction where authorized. | 1 mL |
| Elravie Premier Ultra Volume-L / Ultra Volume-LC | 23 mg/mL | Volume-oriented formulation within the Premier collection, intended for facial soft-tissue correction according to product-specific labeling. | 1 mL / 2 mL |
The concentrations above reflect the identified source documents. Light-L and Light-LC must not be treated as identical specifications without checking their exact labels. The 2 mL Ultra Volume presentation is separately documented; its availability and pack contents depend on the market. Do not assume that all products have identical indications or accessories.
Professional Product Selection Considerations
Professional buyers should compare Elravie Premier formulations according to the exact product name, HA concentration, approved correction profile, lidocaine content and syringe presentation. Different variants within the Premier collection should not be treated as interchangeable.
- Select the Correct Formulation: Distinguish Soft, Light, Deep Line and Ultra Volume using the current product-specific labeling and intended correction profile.
- Verify HA Concentration: Confirm the concentration printed on the actual carton, particularly for Light-L and Light-LC, because manufacturer materials describe different concentration values.
- Confirm Lidocaine Content: The documented lidocaine formulations contain 0.3%. Verify the full product designation and ingredient information rather than assuming all market presentations have the same composition.
- Check Syringe Volume and Accessories: Confirm whether the selected product is a 1 mL or 2 mL presentation, and verify the needle and cannula configuration included in the box.
- Review Regulatory Documentation: Check the original manufacturer, batch number, expiration date, current Instructions for Use and applicable authorization in the destination market.
Storage & Handling
Humedix product information specifies storage at 1–30°C (34–86°F), with protection from light and freezing. Maintain the storage conditions indicated on the original product packaging throughout handling and distribution.
Elravie Premier fillers are sterile, single-use injectable medical devices intended for appropriately qualified healthcare professionals. Do not use products beyond their expiration date or when sterile packaging has been compromised.
Injectable HA fillers can cause adverse reactions, including serious complications such as vascular occlusion and tissue injury. The complete contraindications, warnings and approved indications in the applicable Instructions for Use must be reviewed before clinical use.
Frequently Asked Questions
What is the difference between Elravie Premier Soft, Light, Deep Line and Ultra Volume?
The four formulations differ in HA concentration, material characteristics and intended correction profiles. Soft contains 15 mg/mL HA, while Deep Line and Ultra Volume contain 23 mg/mL. Light is documented at 20 mg/mL in a manufacturer portfolio brochure, while a separately listed Light-LC export presentation specifies 23 mg/mL.
Does Elravie Premier contain lidocaine?
Manufacturer-documented Elravie Premier lidocaine formulations contain 0.3% (3 mg/mL) lidocaine. The exact composition must be confirmed using the product-specific carton and Instructions for Use.
Why do some Elravie Premier Light specifications show different HA concentrations?
Humedix's Premier portfolio brochure identifies Light at 20 mg/mL, while its separate English product page lists Light-LC 1 mL at 23 mg/mL. These listings should not be assumed to describe identical SKUs. Buyers should confirm the exact formulation and concentration from the supplied product label.
Is Elravie Premier Ultra Volume available in 2 mL?
Yes. Humedix product announcements and B2B documentation identify Ultra Volume presentations in both 1 mL and 2 mL. Availability and included accessories must be checked for the specific market and commercial SKU.
Who manufactures Elravie Premier fillers?
Elravie Premier is developed and manufactured by Humedix Co., Ltd., a South Korean company specializing in hyaluronic acid-based pharmaceutical and medical device products.
How should Elravie Premier dermal fillers be stored?
Humedix specifies storage at 1–30°C, protected from light and freezing. Follow the exact requirements printed on the supplied product's original carton and current Instructions for Use.
Product Information Sources
- Humedix — Elravie Premier Soft: Official Composition and Product Information
- Humedix — Elravie Premier Light-LC 1 mL: Official Product Specifications
- Humedix — Elravie Premier Deep Line-LC 1 mL: Official Product Specifications
- Humedix — Elravie Premier Ultra Volume-LC 1 mL: Official Product Specifications
- Humedix — Official Brand Portfolio: Elravie Premier Formulation and Packaging Comparison
